Alexandra Hughes-Wilson

CIK: 0002005875

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (36.4%)

Position reduction

Option Exercises (M)3 (27.3%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MREO

Mereo BioPharma Group plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

MREO
Mereo BioPharma Group plc
Feb 1, 2026
Award(A)
Share Options (Right to buy)
Direct
61.3K shares-
MREO
Mereo BioPharma Group plc
Feb 1, 2026
Award(A)
Share Options (Right to buy)
Direct
183.8K shares-
MREO
Mereo BioPharma Group plc
Feb 1, 2026
Award(A)
Share Options (Right to buy)
Direct
195K shares-
MREO
Mereo BioPharma Group plc
Jan 25, 2025
Award(A)
Share Options (Right to buy)
Direct
154K shares-
MREO
Mereo BioPharma Group plc
Sep 13, 2024
Sale(S)
Direct
16.3K shares at avg. $4.22$69K
MREO
Mereo BioPharma Group plc
Sep 13, 2024
Sale(S)
Direct
84K shares at avg. $4.22$355K
MREO
Mereo BioPharma Group plc
Sep 12, 2024
Sale(S)
Direct
7.8K shares at avg. $4.47$35K
MREO
Mereo BioPharma Group plc
Sep 12, 2024
Sale(S)
Direct
40K shares at avg. $4.47$179K
MREO
Mereo BioPharma Group plc
Sep 11, 2024
Exercise(M)
Direct
75K shares at avg. $1.01$76K
MREO
Mereo BioPharma Group plc
Sep 11, 2024
Exercise(M)
Direct
93.3K shares at avg. $1.40$131K
MREO
Mereo BioPharma Group plc
Sep 11, 2024
Exercise(M)
Direct
40K shares-

		Type	Shares	Price		Ownership
Feb 1, 2026	MREO Mereo BioPharma Group plc	Award(A) Share Options (Right to buy)	61,250	-	-	Direct
Feb 1, 2026	MREO Mereo BioPharma Group plc	Award(A) Share Options (Right to buy)	183,750	-	-	Direct
Feb 1, 2026	MREO Mereo BioPharma Group plc	Award(A) Share Options (Right to buy)	195,000	-	-	Direct
Jan 25, 2025	MREO Mereo BioPharma Group plc	Award(A) Share Options (Right to buy)	154,000	-	-	Direct
Sep 13, 2024	MREO Mereo BioPharma Group plc	Sale(S)	16,304	$4.22	$68,819	Direct
Sep 13, 2024	MREO Mereo BioPharma Group plc	Sale(S)	84,008	$4.22	$354,598	Direct
Sep 12, 2024	MREO Mereo BioPharma Group plc	Sale(S)	7,769	$4.47	$34,748	Direct
Sep 12, 2024	MREO Mereo BioPharma Group plc	Sale(S)	40,029	$4.47	$179,038	Direct
Sep 11, 2024	MREO Mereo BioPharma Group plc	Exercise(M)	75,000	$1.01	$75,750	Direct
Sep 11, 2024	MREO Mereo BioPharma Group plc	Exercise(M)	93,333	$1.40	$130,666	Direct
Sep 11, 2024	MREO Mereo BioPharma Group plc	Exercise(M)	40,000	-	$0	Direct

1-11 of 11 transactions

About Hughes-Wilson Alexandra

Hughes-Wilson Alexandra (SEC CIK 0002005875) files insider reports with the SEC as Officer of Mereo BioPharma Group plc (MREO).

Signal8 holds 4 ownership filings by Hughes-Wilson Alexandra, all Form 4s, filed between Sep 13, 2024 and Feb 2, 2026. Those filings report 11 transactions, from Sep 11, 2024 to Feb 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hughes-Wilson Alexandra's filings is in LONDON, X0.

Recent filings by Hughes-Wilson Alexandra

Feb 1, 2026: Grants or awards of MREO derivative securities (3 lines, Form 4, code A).
Jan 25, 2025: Grant or award of MREO derivative securities (Form 4, code A).
Sep 13, 2024: Open-market sales of MREO shares (2 lines, Form 4, code S).
Sep 12, 2024: Open-market sales of MREO shares (2 lines, Form 4, code S).
Sep 11, 2024: Option exercises of MREO shares (3 lines, Form 4, code M).

Other insiders filing for Mereo BioPharma Group plc (MREO)

Jacquet Pierre, Director
Yoskowitz Marc J, Director
Shames Daniel, Director
Ekblom Anders, Director
Bender Jeremy, Director
PAKIANATHAN DEEPIKA, Director

How to read Form 4 transaction codes